Novel Bioreactor with in-situ Non-Viral Gene Transfer Capabilities for Cell and Gene Therapy Applications (Innolink: 102.464 IP-LS)

• Unité de recherche: INNOSUISSE
• Numéro de projet: 62891.1 IP-LS
• Titre du projet anglais: Novel Bioreactor with in-situ Non-Viral Gene Transfer Capabilities for Cell and Gene Therapy Applications (Innolink: 102.464 IP-LS)

Description succincte (Allemand)

Novel Bioreactor with in-situ Non-Viral Gene Transfer Capabilities for Cell and Gene Therapy Applications (Innolink: 102.464 IP-LS)

Description succincte (Anglais)

Novel Bioreactor with in-situ Non-Viral Gene Transfer Capabilities for Cell and Gene Therapy Applications

Résumé des résultats (Abstract) (Allemand)

Limula develops a novel bioreactor technology that enables end-to-end production of cell and gene therapy products. Leveraging the unique functionalities of this solution, we extend its application scope to next-generation cell therapies that require non-viral gene transfer strategies.